Gain Therapeutics Q1 EPS $(0.16) Beats $(0.18) Estimate
Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 27.27 percent increase over losses of $(0.22) per share from
